Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Mordor Intelligence | PRODUCT CODE: 1437926

Cover Image

PUBLISHER: Mordor Intelligence | PRODUCT CODE: 1437926

India Enteral Feeding Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

PUBLISHED:
PAGES: 72 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4750
PDF (Team License: Up to 7 Users)
USD 5250
PDF (Site License)
USD 6500
PDF (Corporate License)
USD 8750

Add to Cart

The India Enteral Feeding Devices Market size is estimated at USD 389.54 million in 2024, and is expected to reach USD 539.99 million by 2029, growing at a CAGR of 6.75% during the forecast period (2024-2029).

India Enteral Feeding Devices - Market

The COVID-19 pandemic significantly impacted the enteral feeding devices market in India. People with COVID-19 who are very ill may have decreased nutrient absorption since the normal intestinal mucosa has been disturbed in these patients. Immediate enteral nutrition support and the provision of sufficient nutrients are essential to preventing malnutrition in these patients.

Key Highlights

  • According to the report published by the MoHFW, India, in 2022, under the management of shock caused by COVID-19 in children and adolescents (below 18 years), enteral nutrition (EN) should be initiated in ventilated and intubated ICU patients via a nasogastric tube. Hence, the COVID-19 pandemic increased the need for enteral feeding devices. Currently, COVID-19 cases are relatively fewer and continuing in India; it is expected to have a significant impact on the enteral feeding devices market over the coming period.
  • The major factors responsible for the growth of the Indian enteral feeding devices market include the growing geriatric population, an increase in the premature birth rate, an increasing adoption of enteral nutrition, and the high prevalence of chronic diseases.
  • Enteral nutrition (EN) is most commonly required for chronic diseases like neurological conditions that impair swallow function, such as stroke, amyotrophic lateral sclerosis, and Parkinson's disease. Hence the increase in the prevalence of neurological diseases may have a significant impact on the growth of the market.
  • For instance, as per the report published by the Lancet Global Health in July 2021, the largest contributors to the total neurological disorder disability-adjusted life years (DALYs) in India were stroke (379%), headache disorders (175%), epilepsy (113%), cerebral palsy (57%), and encephalitis (53%). Hence, the burden of chronic diseases is growing in India. Chronic patients, who are incapable of taking food, require a good supply of nutrition through enteral feeding, which augments the demand for enteral feeding devices. Therefore, the high prevalence of chronic diseases in India is projected to drive the growth of the market studied over the forecast period.
  • However, complications associated with enteral feeding tubes are the major factors restraining the market's growth.

India Enteral Feeding Devices Market Trends

Oncology Segment Expected to Grow Faster During the Forecast Period

  • Cancer treatment causes many complications and side effects in patients, including mucositis sores in the mouth, difficulty in chewing and swallowing solid food, and altered saliva levels, making it difficult to swallow. The major factor driving the growth of the oncology segment is the rising prevalence of cancer in India. Cancer patients suffer from severe weight loss, as they cannot take proper food, resulting in a shortage of nutrition in the body.
  • According to the study by FICCI and EY, published in October 2022, the number of cancer cases recorded in India in 2022 is predicted to be between 19 and 20 lakh, but the actual number of cancer cases would likely be 1.5 to 3 times higher. Thus proper management is necessary for cancer patients. It has been suggested that one plausible strategy for enhancing clinical outcomes is to offer nutrition support to cancer patients, which can be possible through enteral nutrition. Hence enteral feeding plays a major role in feeding the patient by bypassing the oral route, thus driving the market over the study period.
  • Furthermore, per the report published by the Journal of Nutrition Research in March 2022, home enteral therapy has several benefits for non-hospitalized patients: reducing adverse treatment effects, enhancing weight benefits, and boosting their energy level. Early enteral nutritional therapy lowers the risk of weight loss and malnutrition compared to oral feeding. Thus, the advantages of enteral feeding are likely to create tremendous opportunities for the market.

Adult Underage Group Segment Expected to Have a Significant Growth in the Market

  • The population of the elderly in India has been increasing, which is a major factor driving the market in the region. As the elderly population increases, the risk of chronic diseases increases, which leads to hospitalizations and increases the demand for enteral feeding devices, and is expected to have a significant growth in the market.
  • For instance, as per the study by NSO, in 2021, the proportion of the elderly population in India was projected to be 10.1% in 2021 and 13.1% in 2031. According to the study, the adult population aged above 60 years is considered elderly, and the increasing percentage of the elderly is a key factor for chronic diseases like stroke and cancers in which swallowing becomes difficult. Hence, the study showed a rising in the elderly population, which is expected to increase the demand for enteral feeding due to chronic diseases over the forecast period.
  • According to the report published by VJIM in January 2022, patients who have suffered a brain injury, an ischemic or hemorrhagic stroke, or spinal damage should begin early enteral feeding. All these factors can be seen in adults with comorbidities like hypertension and other factors like sudden falls from heights. Hence with an increase in the elderly population, the risk of stroke and spinal injuries increases, and the demand for enteral feeding is likely to increase, which drives the market over the study period.

India Enteral Feeding Devices Industry Overview

The Indian enteral feeding devices market is moderately competitive, with the presence of global as well as local players. The major players are competing with each other on various fronts, such as the introduction of new products, increasing geographical penetration, and enhancing distribution channels. The high competition is expected to drive the merger and acquisition activities, thereby leading to market consolidation in a few business segments. The major players include Abbott, B. Braun SE, Boston Scientific Corporation, BD (Becton, Dickinson and Company), CONMED Corporation, Cook Medical Incorporated, Fresenius Se & Co. KGaA, Cardinal Health, and Nestle.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Product Code: 62577

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Geriatric Population and High Prevalence of Chronic Diseases
    • 4.2.2 Increasing Premature Birth Rate
  • 4.3 Market Restraints
    • 4.3.1 Complications Associated with Enteral Feeding Tubes
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value- USD million)

  • 5.1 By Product
    • 5.1.1 Enteral Feeding Pump
    • 5.1.2 Enteral Feeding Tube
    • 5.1.3 Other Devices
  • 5.2 By Age Group
    • 5.2.1 Adult
    • 5.2.2 Pediatric
  • 5.3 By End User
    • 5.3.1 Hospital
    • 5.3.2 Ambulatory Care Service
    • 5.3.3 Other End Users
  • 5.4 By Application
    • 5.4.1 Oncology
    • 5.4.2 Gastroenterology
    • 5.4.3 Diabetes
    • 5.4.4 Neurological Disorder
    • 5.4.5 Hypermetabolism
    • 5.4.6 Other Applications

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott
    • 6.1.2 B. Braun SE
    • 6.1.3 Boston Scientific Corporation
    • 6.1.4 BD (Becton, Dickinson and Company)
    • 6.1.5 CONMED Corporation
    • 6.1.6 Cook Medical Incorporated
    • 6.1.7 Fresenius Se & Co. KGaA
    • 6.1.8 Cardinal Health
    • 6.1.9 Nestle

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!